Top

Journal of Assisted Reproduction and Genetics

Published in:

01-09-2015 | Reproductive Physiology and Disease

Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome

Authors: Maya Kriseman, Charity Mills, Ertug Kovanci, Haleh Sangi-Haghpeykar, William Gibbons

Published in: Journal of Assisted Reproduction and Genetics | Issue 9/2015

Abstract

Purpose

The purpose of this paper is to determine whether antimullerian hormone (AMH) levels were associated with BMI in patients with diagnosed infertility, and more specifically, in patients with polycystic ovarian syndrome (PCOS).

Methods

A retrospective cohort study reviewed all females who presented to the clinical investigators’ practice between November 2011 and March 2013. The following data was retrieved from the medical record: (1) AMH level, (2) age, (3) BMI, (4) ethnicity, and (5) if infertile, etiology of infertility.

Results

AMH levels were available for 489 women. Of these, 104 were diagnosed with PCOS. Overall, there was no association between BMI and AMH (r −0.04, p > 0.05). On the other hand, in the women with PCOS, there was a significant association between BMI and AMH (r −0.31, p < 0.01).

Conclusions

BMI was not associated with AMH levels in the general population of infertile women or in patients without PCOS. However, BMI appeared to be significantly and inversely correlated with AMH in women with PCOS.

Durlinger AL et al. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction. 2002;124(5):601–9.CrossRefPubMed

Siefer DB et al. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95(2):747–50.CrossRef

Köninger A et al. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Hum Reprod. 2014;29(3):518–24.CrossRefPubMed

Jonard S et al. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107–17.CrossRefPubMed

van Rooij A et al. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17(12):3065–71.CrossRefPubMed

Tal R et al. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119–30.e3.CrossRefPubMed

Kissell KA. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod. 2014;29(8):1764–72.PubMedCentralCrossRefPubMed

Sheehan M. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2(1):13–27.PubMedCentralCrossRefPubMed

March WA et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–51.CrossRefPubMed

10.

Homburg et al. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod. 2013;28(4):1077–83.CrossRefPubMed

11.

Caglar, et al. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS. Arch Gynecol Obstet. 2013 Apr 4.

12.

Karkanaki A et al. The clinical significance of anti-Mullerian hormone evaluation in gynecological endocrinology. Horm. 2011;10(2):95–103.CrossRef

13.

Piouka A et al. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296(2):E238–43.CrossRefPubMed

14.

Amer SA et al. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study. Reprod Biol Endocrinol. 2013;11:115.PubMedCentralCrossRefPubMed

15.

Mahran A et al. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. J Clin Endocrinol Metab. 2013;98(10):4170–5.CrossRefPubMed

16.

Panidis D. Serum LH levels are markedly increased and significantly correlated with Delta 4-androstendione levels in lean women with polycystic ovary syndrome.2005. Fertil Steril 84: 538–540.

17.

Katsikis I, et al. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. 2011. Eur J Obstet Gynecol Reprod Biol

18.

McDowell S et al. Clomiphene ovulation induction and higher-order multiple pregnancy. Aust N Z J Obstet Gynaecol. 2013;53(4):395–8.CrossRefPubMed

19.

Bailey AP et al. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. Am J Obstet Gynecol. 2014;211(2):163–e1-6.PubMed

Title: Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome
Authors: Maya Kriseman
Charity Mills
Ertug Kovanci
Haleh Sangi-Haghpeykar
William Gibbons
Publication date: 01-09-2015
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 9/2015
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-015-0540-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2015

Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women

Association between IL-6 −174 G/C, IL-6 −634 G/C, and IFN-γ +874 A/T polymorphisms and susceptibility to recurrent pregnancy loss: a meta-analysis

Ultrastructural markers of quality are impaired in human metaphase II aged oocytes: a comparison between reproductive and in vitro aging

Reduced blastocyst formation in reduced culture volume

Phospholipase C-zeta deficiency as a cause for repetitive oocyte fertilization failure during ovarian stimulation for in vitro fertilization with ICSI: a case report

Increased body mass index negatively impacts blastocyst formation rate in normal responders undergoing in vitro fertilization